Poll: Which of the following is true about insulin products and the BPCIA?

Many patient advocates hope that expansion of the Biologics Price Competition and Innovation Act (BPCIA) will bring further competition to the insulin market—and lower prices.

Related Content:

PollsRegulatoryBusiness

FDA Approves Steqeyma for Children With Plaque Psoriasis, Psoriatic Arthritis

Eye on Pharma: Keytruda Biosimilar Deal; German Court Bans Imraldi; New Biosimilars for Japan

Sandoz, STADA, and Samsung Bioepis Report Strong Earnings From Biosimilars